FAFGX | SCGSX | FAFGX / SCGSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 24 years | - |
Gain YTD | 30.017 | 28.413 | 106% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 306B | 2.32B | 13,167% |
Annual Yield % from dividends | 0.69 | 0.00 | - |
Returns for 1 year | 31.57 | 27.33 | 116% |
Returns for 3 years | -0.33 | -1.07 | 31% |
Returns for 5 years | N/A | 57.02 | - |
Returns for 10 years | N/A | 66.34 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VINAX | 141.35 | 0.16 | +0.11% |
Vanguard Industrials Index Admiral | |||
COGMX | 12.71 | -0.01 | -0.08% |
AXS Market Neutral Inv | |||
NWAYX | 17.60 | -0.03 | -0.17% |
Nationwide GQG US Quality Eq Eagle | |||
TGWFX | 15.55 | -0.09 | -0.58% |
Transamerica Large Growth R4 | |||
ETIHX | 36.50 | -0.27 | -0.73% |
Eventide Healthcare & Life Sciences I |